Committee stage & Committee: 2nd sitting (Hansard) & Committee: 2nd sitting (Hansard): House of Lords
Thursday 1st October 2020

(4 years, 1 month ago)

Grand Committee
Read Full debate Trade Bill 2019-21 View all Trade Bill 2019-21 Debates Read Hansard Text Read Debate Ministerial Extracts Amendment Paper: HL Bill 128-III Third marshalled list for Grand Committee - (1 Oct 2020)
Viscount Trenchard Portrait Viscount Trenchard (Con)
- Hansard - - - Excerpts

My Lords, I understand the intention of the noble Lord, Lord Grantchester, and the other noble Lords who have signed his Amendment 12. As the Committee should be aware, the United Kingdom has been a leader in standing up internationally for high environmental standards around the world. As the Minister made clear at Second Reading, all the continuity agreements that we have been and are negotiating are fully compliant with our international obligations, including the Paris Agreement on climate change. It is unnecessary to constrain the Government’s freedom in negotiating trade agreements with countries, including developing countries which may not have adopted the same environmental standards as we have, because that might have unintended consequences. Furthermore, the Paris Agreement targets only carbon reduction, but does not fully address the equally great national security challenge of providing clean energy for the whole planet, particularly in a world that needs more energy, not less.

As for Amendment 14 in the name of the noble Lord, Lord Stevenson of Balmacara, and my noble friend Lady McIntosh of Pickering, I am not quite sure what its purpose is. As I understand it, it would prohibit the application of the powers created in this clause for the purposes of an enhanced continuity trade agreement such as that which we have agreed with Japan. Why would the noble Lord and my noble friend wish unduly to restrict the freedom of our negotiators to take any available opportunity to include enhancements to any continuity agreement?

As for Amendment 21 in the name of the noble Lord, Lord Oates, I oppose it for the reason suggested by my noble friend Lord Lansley. It seems to me that it is designed to prevent a trade agreement with the United States, and that would have a negative effect on the economy and deny opportunities to British exporters and food producers.

Amendment 40, also in the name of the noble Lord, Lord Oates, is similarly unnecessary. In any case, your Lordships have received repeated assurances that none of our continuity agreements will deviate from the high standards that we apply to environmental issues, similar to human rights, as debated in a previous group. The Minister has already reassured the Committee that the Government will continue to publish parliamentary reports with each continuity agreement.

It will not surprise my noble friend Lady McIntosh of Pickering to hear that I do not support her Amendment 69. It is clear that the Food Standards Agency has the powers to permit, or not, the sale of any foods which might be imported under FTAs. The amendment also seeks to require alignment of our agricultural marketing standards with those of the EU, which we have left. I agree with my noble friend that high animal welfare standards are a laudable objective, and we have done relatively well in this country in this area. However, I think she is incorrect to argue that animal welfare is exactly the same as animal health and hygiene. We will be free to set our own regulations after the end of the transition period. I earnestly trust that we will move quickly to adopt standards that are WTO compliant, unlike those of the EU, which in certain respects conflict with the WTO’s SPS agreement.

As my noble friend the Minister said at Second Reading, it is not within the gift of the UK Parliament to legislate on animal welfare standards for overseas countries. The Government have been clear that we have no intention of lowering standards, and we have fulfilled this commitment through our deeds. None of the 20 agreements already signed has reduced standards in any area. As the Minister said at Second Reading, it will be the job of the food standards agencies to ensure that all food imports comply with the UK’s high safety standards and that consumers are protected from unsafe food that does not meet those standards. Decisions on those standards are a matter solely for the UK and are made separately from any trade agreements. I ask the Minister to confirm that that remains the Government’s position.

For similar reasons, I am also opposed to Amendments 73 and 74 in the name of the noble Baroness, Lady Jones of Moulsecoomb. In any case, does my noble friend the Minister not agree that the Government would obviously not seek to enter into an international trade agreement without any merit with any nation? Neither should we expect only to enter into agreements which share precisely our positions on all multilateral environmental agreements.

Baroness Northover Portrait Baroness Northover (LD) [V]
- Hansard - -

My Lords, there is surely nothing more important than addressing climate change, as the noble Baroness, Lady Hayman, and others have made clear. It is difficult to see that any trade agreement could possibly be justified if it is in contradiction to what must be an overriding national and international aim. Trade agreements must at the very least be consistent with our climate goals, and certainly must not undermine those commitments. I am sure that the noble Viscount will note the cross-party nature of many of these amendments.

My noble friend Lord Oates is very sorry that he cannot be here today, as he is attending a funeral. Amendment 12 in the name of Lord Grantchester and others, including my noble friend Lord Oates, means that any trade agreement we make must be consistent with our commitments under the Paris climate change agreement, CITES and the Convention on Biological Diversity. That is surely a given, and yet we know that this does not mean that such aims are built into trade deals. In Amendment 21, my noble friend Lord Oates and others make the case here stronger still: that trade deals can be made only with those who have signed up to the Paris Agreement, or not served notice that they intend to leave.

If after the debate we heard in the United States this week the American people decide that they wish to have Mr Trump as President for the next four years, then no trade deal could be undertaken with the United States, which will have pulled out of the Paris Agreement by then, having given the necessary three years’ notice and a fourth year to implement that—the four-year provision that President Obama very sensibly put into the Paris Agreement.

--- Later in debate ---
Lord Rooker Portrait Lord Rooker (Lab) [V]
- Hansard - - - Excerpts

My Lords, I will intervene only briefly, initially to support my noble friend Lord Bassam in some of the examples he gave. Dispute settlement in trade deals is pretty important as is what is put into the deal. I am not clear about—but I hope I am—whether “public services” includes critical infrastructure. As far as I am concerned, the two go together. I would cite energy, for a start, because one can see the problems we are going to have with energy in this country with the collapse of the nuclear deal. We must have a mix. There is a good chance that the lights and the gas may go out and the Government may want to move at some point to take monopoly control of the service. They ought to be able to do that, but there are too many sticky fingers for my liking in the issues involved and therefore I think the idea behind the amendment by my noble friend Lord Bassam is very good.

I want to make a brief point about Amendment 51 on the health service. I thought the speech by the noble Lord, Lord Patel, was devastating with its list of companies. Do not get me wrong, I have no objection to the NHS or other public services using the best available management tools, techniques and individuals to provide services but making use of them is not the same as handing over ownership. That is where one has to draw the line. The noble Lord, Lord Patel, made a very fair point. The public do not care who is providing the service as long as it is there when they need it, free at the point of use. He went on to say that they will care when their taxes go up. That point is when someone, such as the Prime Minister, will say, “You can avoid that by buying some insurance.” It is the slippery road to push us down the insurance route. I know we are all nice people in the Lords but frankly I do not trust the Prime Minister.

Baroness Northover Portrait Baroness Northover (LD) [V]
- Hansard - -

My Lords, many of the debates here take me back to 2012, and I look forward to the contribution from my former boss, the noble Lord, Lord Lansley. I want to speak in support of Amendment 75 in the name of my noble friend Lady Sheehan. She has laid the amendment out effectively and comprehensively. There has long been tension between those marketing and those purchasing proprietary medicines and generics. Clearly, where pharmaceutical companies invest in research and development they should be rewarded for that, but we also know how expert the industry is at claiming R&D when that is beyond what they have actually done.

This issue plays out in the NHS but also internationally, particularly in developing countries where basic medicines may not be affordable and dependence on generics is vital. As the noble Baroness, Lady Finlay, said, the pandemic has shown how important this is. It reinforces that we are all interlinked. An infection that affects the community in one part of the world is within days potentially spread worldwide. It is in all our interests that disease is countered everywhere, as well as that being the right thing to do.

As my noble friend Lady Sheehan said, Amendment 75 affirms the Government’s right to use internationally agreed safeguards to protect public health, including securing access to more affordable generic medicines. As she said, earlier FTAs often focused on tariffs and trade in goods, while in the past couple of decades FTAs have become more comprehensive. Of course, many such developments are welcome in terms of ensuring standards, as we have been discussing, but provisions can also inappropriately protect monopolistic business. As I have said, genuinely innovative companies have a case, but their role can be exploited. In recognition of this, the WTO’s TRIPS agreement included public health safeguards. These were reaffirmed in the 2001 Doha declaration. Protecting genuine innovation has therefore already been addressed by the WTO, and it is important that these proposals are taken forward. I look forward to hearing the Minister’s response.